Apyx Medical
APYX
39 hedge funds and large institutions have $35.6M invested in Apyx Medical in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 7 closing their positions.
64% more capital invested
Capital invested by funds: $21.6M → $35.6M (+$13.9M)
0.04% more ownership
Funds ownership: 41.79% → 41.84% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 43 → 39 (-4)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
+$352K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$113K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$110K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$31.3K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$30.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
-$139K |
| 2 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$124K |
| 3 |
RA
Royce & Associates
New York
|
-$121K |
| 4 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
-$48.9K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$42.2K |
APYX Hedge Fund Activity: Q2 2025 in Review
39 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2025, worth a combined $35.6M — up 64% from $21.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of APYX and 4 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 10 added.
The largest buyer was Silverberg Bernstein Capital Management, adding an estimated $352K. The largest seller was Rathbones Group, exiting entirely with an estimated $139K sold.
- 39 institutional investors held Apyx Medical (APYX) as of Q2 2025, down from 43 in Q1 2025.
- Funds reported $35.6M of Apyx Medical stock for Q2 2025, up 64% quarter-over-quarter.
- 4 funds opened new Apyx Medical positions in Q2 2025 and 7 closed out, a net change of -3 holders.
- The largest Apyx Medical buyer in Q2 2025 was Silverberg Bernstein Capital Management, an estimated $352K added.
- The largest Apyx Medical seller in Q2 2025 was Rathbones Group, an estimated $139K sold.
Based on aggregated 13F filings for Q2 2025.